There's a lot of exciting therapies that have emerged over the last 10 years and there's more therapies coming down the ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...

Nektar’s shares have surged more than twofold after a Phase IIb study of its atopic dermatitis (AD) therapy rezpegaldesleukin ...

Dupilumab use in asthma is linked to higher lymphoma risk, especially T and NK cell types, but also shows reduced all-cause ...

Sanofi SNY and its partner, Regeneron REGN, announced that the FDA has approved their blockbuster medicine, Dupixent ...